Roberto Luksch

26PUBLICATIONS
136CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursHaematological tumoursNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 29, 2026
The VIVA Regimen (Vinorelbine, Ifosfamide, Vincristine, and Actinomycin-D) for High-Risk Rhabdomyosarcoma: Feasibility and Outcomes From a Single-Institution Study.

|Jul 23, 2026
Association Between Dinutuximab Beta Exposure and Post-End-of-Treatment Survival in Neuroblastoma: A Weighted Patient-Level Analysis of Three Clinical Studies.

|Mar 25, 2026
Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials.

Elisa Tirtei, Valeria Difilippo, Federico Divincenzo

|Jul 08, 2025
Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion Trial.

Holger N Lode, Nikolai Siebert, Dominique Valteau-Couanet

|May 31, 2025
Pediatric Craniofacial Osteosarcoma: The Milano Experience.

Cristina Meazza, Francesca Parisi, Francesco Barretta

|May 21, 2025
Malignant Peripheral Nerve Sheath Tumor in Children and Adolescents: Local Treatment in a Retrospective Single-Center Experience.

Andrea Ferrari, Luca Bergamaschi, Stefano Chiaravalli

Pageof 5

Frequent Collaborators

17 joint publications

Andrea Ferrari

16 joint publications

Maura Massimino

15 joint publications

Monica Terenziani

13 joint publications

Cristina Meazza